Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 16, 2022

SELL
$1.21 - $2.7 $2,513 - $5,607
-2,077 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$2.59 - $3.36 $4,814 - $6,246
1,859 Added 852.75%
2,077 $6,000
Q2 2021

Aug 16, 2021

BUY
$3.11 - $4.87 $18 - $29
6 Added 2.83%
218 $1,000
Q1 2021

Aug 17, 2021

BUY
$3.66 - $7.67 $775 - $1,626
212 New
212 $1,000

Others Institutions Holding GNPX

About Genprex, Inc.


  • Ticker GNPX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,020,300
  • Market Cap $76.8M
  • Description
  • Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incor...
More about GNPX
Track This Portfolio

Track Harbour Investments, Inc. Portfolio

Follow Harbour Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Harbour Investments, Inc. with notifications on news.